Number 1 Exercise and diet Book on the Internet. Click Here To Learn More
Fat Loss for Idiots 

Print This Post Print This Post Email this Article to a friend Email this Article to a friend

At the American Heart Association conference yesterday a new study was released that showed that Pfizer’s cholesterol drug Lipitor, showed no significant reduction in “major coronary events” versus rival treatment Merck’s Zocor.

The five-year study found no statistically significant difference between Lipitor and US drugmaker Merck’s Zocor in reducing heart disease-related death, heart attack and cardiac arrest. Results of the study were presented on Tuesday at an American Heart Association conference.

The study did show a difference in some secondary targets. Lipitor was 13 per cent better than Zocor in reducing major heart events when strokes were included.

The comparison between Lipitor and Zocor is important for Pfizer. The world’s largest drugmaker continuously seeks to develop an extensive body of data that will persuade doctors that Lipitor, the biggest-selling drug in the world with $12 billion, yes that is Billion dollars in sales this year, is better than older, cheaper drugs from the same statin class of cholesterol reducers. Pfizer wants to preserve sales in the face of generic versions of Zocor, whose US patent expires next year.

As we all know when a patent expires any company can recreate copycat drugs that are much cheaper than the original drugs were. These generic drugs are opposed with billions of dollars by the drug companies to protect their patents and to try to recoup more money from the research that went into creating drugs like Lipitor or Zocor in the first place.

The new study compared the highest dose of Lipitor to relatively average doses of Zocor in who had had a previous heart attack.

Lipitor had 17 per cent fewer non-fatal heart attacks in the study versus patients on Zocor, and significant reduction in other heart problems requiring medical attention.

But there was no difference in the overall death rate between the two treatments.

Help other people discover this post
  • del.icio.us
  • YahooMyWeb
  • StumbleUpon
  • Digg
  • HealthRanker
  • Yahoo! Buzz
  • email
  • Facebook
  • Twitter
  • Add to favorites
  • MySpace

Looking to make a change and lose some weight? I have reviewed the top diet on the internet and you can go and read over 200 comments people have made about why this diet has worked well for them, as well as some of the problems.

Tags: American Heart Association, cardiac arrest, heart attack, heart attacks, heart disease, lipitor, Merck, pfizer, United States, USD, Zocor

If you like this post then you will probably like these other related items as well

  • Lipitor to face cheap generics for market share
  • Lipitor for chronic Angina?
  • Does Aspirin Really Lower Heart Attack Risk?
  • New Special Pill to Prevent Heart Disease
  • Cholesterol and you
  • 2 Responses to “Lipitor versus Zocor for lowering Cholestorol”
    1. shelly says:

      Thank you for sharing。i have some imformation to help you in my blog

    2. Amelia says:

      India is the ultimate travel experience in my opinion. It can burn you out and that for sure, but not to be missed. :)
      If you are around the Taj Mahal next Christmas have a coffee with me.

    3.  
    Leave a Reply